Hemispherx BioPharma (HEB)

[Kate4]

Apparently at the conference last week HEB presented data comparing Alferon to Relenza. I haven't listened, but here's what it said in the press release:

Comparative analysis will be presented on Alferon(R) LDO (an investigational biologic) versus a present standard of clinical care for both seasonal and pandemic influenza utilizing a monkey (macaque) model system. Both products (Alferon(R) LDO and a neuraminidase inhibitor, Relenza(R)) have been evaluated under similar test conditions by third party, independent researchers. The magnitude of lung protection with each product will be discussed at different concentration ranges.

http://www.marketwatch.com/story/hemispherx-biopharma-presents-at-the-rodman-healthcare-conference-2009-09-02